Sharon M Barr

Title: Innovations by Sharon M Barr

Introduction

Sharon M Barr is a notable inventor based in Huntington, NY (US). She has made significant contributions to the field of cancer treatment through her innovative patents. With a total of three patents to her name, her work focuses on enhancing the effectiveness of cancer therapies.

Latest Patents

One of her latest patents involves a combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors. This invention provides a method for treating tumors or tumor metastases in a patient by administering a therapeutically effective amount of a combination of an EGFR kinase inhibitor and an mTOR inhibitor. The mTOR inhibitor binds to and directly inhibits both mTORC1 and mTORC2 kinases. A preferred example of an EGFR kinase inhibitor used in this method is erlotinib HCl, also known as TARCEVA®. Another patent focuses on treating non-small cell lung cancer, pancreatic, colon, or breast cancer tumors using a similar combination of agents.

Career Highlights

Sharon M Barr is currently associated with Osi Pharmaceuticals, Inc., where she continues to develop her innovative ideas. Her work has the potential to significantly impact cancer treatment protocols and improve patient outcomes.

Collaborations

Some of her notable coworkers include Elizabeth Buck and Graeme Griffin, who contribute to her research and development efforts.

Conclusion

Sharon M Barr's innovative work in cancer treatment exemplifies the importance of combining therapies to enhance effectiveness. Her contributions are paving the way for advancements in oncology.